Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook


 


 

Human stem cells reverse multiple sclerosis in mice

19 May 2014

By Alice Plein

Appeared in BioNews 754

Mice with a viral form of multiple sclerosis (MS) are able to walk again after receiving a transplant of human stem cells, scientists report.

Researchers had injected neural stem cells into the spinal cord of the mice expecting them to be rejected, but instead they witnessed a surprising recovery.

Professor Tom Lane from the University of Utah, who led the research group, said: 'My postdoctoral fellow Dr Lu Chen came to me and said, "The mice are walking". I didn’t believe her'.

The study opens up a new research area for patients with MS, which affects 2.3 million people worldwide. In MS, the body’s immune system targets myelin, the fatty insulation surrounding nerve fibres. This leads to impaired nerve signal transmission, causing widespread symptoms such as loss of vision and motor skills, fatigue, and slurred speech. At present, drugs that dampen the immune system can slow down the early stages of the disease but there is no treatment for patients at the latter stages of MS.

The scientists transformed human embryonic stem cells into neural precursor cells, which have the potential to develop into all the types of cell in the nervous system. Once injected into the mice, they released chemicals that eased the symptoms of MS. This was a result of an unusually low number of neural precursor cells being grown within each lab dish, which meant that more beneficial proteins were released after transplantation.

The exact nature of these proteins remains to be discovered, but the researchers believe that they hold the potential for future treatments.

Professor Lane explained 'Rather than having to engraft stem cells into a patient, which can be challenging from a medical standpoint, we might be able to develop a drug that can be used to deliver the therapy much more easily'.

Dr Sorrel Bickley, from the MS Society, commented: 'This is an interesting, early-stage study that's given scientists new ideas for future research into potential MS therapies. It's not currently being planned for testing in people, but it's a useful avenue for scientists to explore – we look forward to seeing how this area of research develops'.

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

25 January 2016 - by Dr Lanay Griessner 
A stem cell treatment routinely used for bone and blood cancers is showing promise at reversing the effects of multiple sclerosis...
26 May 2015 - by Kirsty Oswald 
Researchers have found a way to directly convert blood cells into nerve cells of both the central and peripheral nervous system....
26 January 2015 - by Dr Tamara Hirsch 
An early clinical trial investigating a new form of stem cell therapy for multiple sclerosis has demonstrated neurological improvement and enhanced quality of life for patients...
26 August 2014 - by Dr Lux Fatimathas 
Scientists have generated the specialised cells in the embryo that go on to form spinal cord, muscle and bone tissue and used them to produce nerve and muscle cells...
09 June 2014 - by Isobel Steer 
Human embryonic stem cells have been shown to be more effective in treating multiple sclerosis (MS) in mice than bone marrow stem cells, a study has found...

07 October 2013 - by Julianna Photopoulos 
A group of international researchers has identified 48 new genetic variants that influence the risk of developing multiple sclerosis. This brings the number of genetic 'risk factors' linked to the disease to 110...
22 April 2013 - by Dr Anna Cauldwell 
Skin cells have been directly converted into the types of cells destroyed in patients with myelin disorders like multiple sclerosis and cerebral palsy in a pair of studies on mice...
07 January 2013 - by Dr Tamara Hirsch 
Neural stem cells were shown to be effective against amyotrophic lateral sclerosis (ALS), or motor neurone disease, in 11 independent studies on mice with the disease...
28 May 2012 - by Dr Lux Fatimathas 
A chemical produced by stem cells promotes recovery in mice with the autoimmune neurological disease, multiple sclerosis. Hepatocyte growth factor, which is produced by human mesenchymal stem cells, appeared to both repair existing damage and prevent future neurological harm in a mouse model of the disease...

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust

CROSSING FRONTIERS

Public Conference
London
8 December 2017

Speakers include

Professor Azim Surani

Professor Magdalena Zernicka-Goetz

Professor Robin Lovell-Badge

Sally Cheshire

Professor Guido Pennings

Katherine Littler

Professor Allan Pacey

Dr Sue Avery

Professor Richard Anderson

Dr Elizabeth Garner

Dr Andy Greenfield

Dr Anna Smajdor

Dr Henry Malter

Vivienne Parry

Dr Helen O'Neill

Dr César Palacios-González

Philippa Taylor

Fiona Fox

Sarah Norcross

Sandy Starr


BOOK HERE

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation